PULSE BIOSCIENCES INC(NASDAQ:PLSE) stock News

PLSE Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

4 days ago - By: Zacks Investment Research - Mentions: EW MASI NDRA

Pulse Biosciences Unveils Promising First-in-Human Data for nPulse

7 days ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

10 days ago - By: Pulse Biosciences

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

a month ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

a month ago - By: Pulse Biosciences, Inc.

Pulse Biosciences’ nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

a month ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

a month ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Benzinga - Mentions: MSC ELUT ACIW JYNT ...

Earnings Scheduled For May 8, 2025

2 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

2 months ago - By: Zacks Investment Research - Mentions: BSX WST MEDP

PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment

2 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

2 months ago - By: The Motley Fool

Pulse Biosciences Cash Jumps in Q2

2 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

2 months ago - By: Benzinga - Mentions: BKV IMCC VALN PRTS ...

Earnings Scheduled For August 12, 2025

3 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

3 months ago - By: Pulse Biosciences

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

3 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

5 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

6 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

6 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

6 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

6 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

7 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

7 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

7 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

8 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

8 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

9 months ago - By: Pulse Biosciences, Inc.

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

9 months ago - By: Pulse Biosciences, Inc.

PULSE BIOSCIENCES INC (PLSE) Stock News

PLSE Latest News, Press Relases and Analysis

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Unveils Promising First-in-Human Data for nPulse

Pulse Biosciences Announces Presentation of Late-Breaking Data From the nPulse™ Cardiac Surgical System First-in-Human Feasibility Study at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Pulse Biosciences Announces Clinical Data Highlighting its nPulse™ Cardiac Surgical System to be Presented at the 39th European Association for Cardio-Thoracic Surgery Annual Meeting

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences’ nPulse™ Technology to be Featured at the American Thyroid Association 2025 Annual Meeting

Pulse Biosciences Announces FDA IDE Approval to Initiate its nsPFA Cardiac Surgery System Study for the Treatment of Atrial Fibrillation

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Earnings Scheduled For May 8, 2025

Pulse Biosciences Announces First Successful Procedures in PRECISE Benign Thyroid Nodule (BTN) Study

PLSE Shares Rise on First-in-Human Data for Thyroid Nodule Treatment

Pulse Biosciences Announces Publication of First-In-Human Data for Treatment of Benign Thyroid Nodules in the Journal Thyroid

Pulse Biosciences Cash Jumps in Q2

Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results

Earnings Scheduled For August 12, 2025

Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference

Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results

Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025

Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting

Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results

Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting